1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > World Flow Cytometry - Market Opportunities and Forecast, 2014 - 2022

Flow cytometry is a biophysical, laser based analytical technology that measures and analyses several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam. Flow cytometry has various advantages over traditional analytical methods such as ELISA, which include its ability to deliver precise and accurate results and lesser time consumption at about same prices. The flow cytometry technology is widely used in the various fields of academic and clinical research, and diagnosis of diseases such as cancer, HIV and hematological malignancies. Rising count of patients suffering from HIV and cancer and increasing use of flow cytometry in hospitals and diagnostic centers, has created an impending need of flow cytometry in the effective diagnosis and monitoring of diseases.World flow cytometry market is set to grow at a remarkable pace in the coming years, attributed to technological advancements and high adoption in various research and diagnostic applications. In addition, the advent of flow cytometry technology in novel research applications such as cytogenomics, proteomics and marine biology would further supplement the market growth. Further, rising incidence rates of diseases such as cancer and HIV are likely to boost the adoption of flow cytometry technology across diagnostic applications. On the other hand, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users and the limited availability of technical expertise are likely to impede the market growth. The preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.The world flow cytometry market is estimated to reach $7.0 billion by 2022, registering a CAGR of 16.0% over the forecast period. The report segments the world flow cytometry market based on components, technologies, applications, end users and geography. Based on components, the market is segmented into instruments, reagents, software and services. Instruments accounted for the highest revenue-generating segment in 2014, owing to the technological advancements, demand for highly efficient replaceable components and widening scope of flow cytometry applications in newer diseases. Based on technology, the market is segmented into bead based and cell based technologies. Cell based flow cytometry would constitute the highest revenue generating segment throughout the forecast period due to its widespread use across all the applications. Based on application, world flow cytometry market is segmented into academic and clinical research, and diagnostic applications. Academic and clinical research application was the major revenue generating segment in 2014, however, diagnostics segment is projected as the fastest growing segment. The world flow cytometry end users market is segmented into commercial organizations, medical schools and research labs, hospitals, academics and others. Commercial organizations was the highest revenue generating end-user segment in 2014, due to high adoption of flow cytometry in drug discovery process and clinical research.Based on geography, the market is segmented across North America, Europe, Asia-Pacific and LAMEA. North America was the leading region in 2014, supplemented by rapid technological advancements, high R&D investment and widespread use of flow cytometry in research and diagnostic activities. Asia Pacific region would emerge as the most lucrative market over the forecast period owing to outsourcing of R&D activities in this region and increasing incidences of diseases such as cancer and HIV.The report provides a comprehensive analysis of the leading companies operating in the world flow cytometry market. Key companies profiled in the report are Danaher Corporation (Beckman Coulter), Becton, Dickinson and Company , EMD Millipore, Sysmex Corporation, Affymetix Inc., Luminex Corporation, Thermo Fischer Scientific, Bio-Rad Laboratories, Inc., Miltenyi Biotec, Inc. and Agilent Technologies, Inc.KEY MARKET BENEFITS:The study provides an in-depth analysis of the world flow cytometry market with current and future trends to elucidate the imminent investment pockets in the market.The report provides a quantitative analysis through 2014-2022, which would enable the stakeholders to capitalize on prevailing market opportunities.Extensive analysis of the world flow cytometry market, by component, helps in understanding the components of the flow cytometer that are currently used along with the variants that would gain prominence in the futureCompetitive intelligence highlights the business practices followed by leading market players across various geographiesSWOT analysis enables to study the internal and external environment of the leading companies for strategy formulation

KEY MARKET SEGMENTS
:The world flow cytometry market is segmented as:World Flow Cytometry Market By ComponentInstrumentsCytometry platformsSortersAnalyzersReplaceable componentsFilterLaserDetectorsOthersAccessoriesReagents and consumablesAntibodiesDyesBeadsSolutionsBuffersOthersSoftwareServicesWorld Flow Cytometry Market By TechnologyBead based flow cytometryCell based flow cytometryWorld Flow Cytometry Market By ApplicationAcademic and clinical research applicationsCell cycle analysis and cell proliferationApoptosisSorting and screeningTransfection and cell viabilityOthersDiagnosis applicationsOrgan transplantationHematological malignanciesCancer and solid tumorsImmunodeficiency diseases- HIV infectionOthersWorld Flow Cytometry Market By End usersCommercial organizationsMedical schools and clinical labsHospitalsAcademicsOthersWorld Flow Cytometry Market By GeographyNorth AmericaEuropeAsia-PacificLAMEA

Table Of Contents

World Flow Cytometry - Market Opportunities and Forecast, 2014 - 2022
Table of ContentsCHAPTER 1 INTRODUCTION1.1 Report description1.2 Key benefits1.3 Research methodology1.3.1 Secondary research1.4 Primary research1.4.1 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARY2.1 CXO perspectiveCHAPTER 3 MARKET OVERVIEW3.1 Market definition and scope3.2 Key findings3.2.1 Top impacting factors3.2.2 Top investment pockets3.2.3 Top winning strategies3.3 Porters five forces analysis3.3.1 Low bargaining power of suppliers3.3.2 High bargaining power of buyers3.3.3 Low threat of new entrants3.3.4 High competitive rivalry3.3.5 Low threat of substitutes3.4 Market share analysis, 20143.5 Reimbursement scenario3.6 Regulatory issues3.6.1 Challenges in FDA clearance3.6.2 Impact of ASR rule3.6.3 Validation challenges: cellbased3.6.4 Validation requirements (CLIA, CAP)3.6.5 LDT guidelines on cellbased fluorescence3.6.6 Change in regulations3.7 Drivers3.7.1 Technological advancements3.7.2 Large scale adoption of flow cytometry technique in research and diagnosis applications3.7.3 Increasing applications across novel fields3.7.4 Augmented Randamp;D investment3.7.5 Rising incidences of HIV and cancer3.8 Restraints3.8.1 High cost of instrument3.8.2 Lack of awareness among consumers3.8.3 Limited technical expertise3.9 Opportunities3.9.1 Lucrative opportunities in diagnostics3.9.2 Emerging role of flow cytometry in drug discovery and developmentCHAPTER 4 WORLD FLOW CYTOMETRY MARKET, BY COMPONENT, 2014-20224.1 Overview4.1.1 Market size and forecast4.2 Instruments4.2.1 Key market trends4.2.2 Competitive landscape4.2.3 Key growth factors and opportunities4.2.4 Market size and forecast4.2.5 Platforms4.2.5.1 Market size and forecast4.2.5.2 Sorters4.2.5.2.1 MARKET SIZE AND FORECAST4.2.5.3 Analysers4.2.5.3.1 MARKET SIZE AND FORECAST4.2.6 Replaceable components4.2.6.1 Market size and forecast4.2.6.2 Filters4.2.6.2.1 MARKET SIZE AND FORECAST4.2.6.3 Lasers4.2.6.3.1 MARKET SIZE AND FORECAST4.2.6.4 Detectors4.2.6.4.1 MARKET SIZE AND FORECAST4.2.6.5 Others4.2.6.5.1 MARKET SIZE AND FORECAST4.2.7 Accessories4.2.7.1 Market size and forecast4.3 Reagents and consumables4.3.1 Competitive landscape4.3.2 Key growth factors and opportunities4.3.3 Market size and forecast4.3.4 Antibodies4.3.4.1 Market size and forecast4.3.5 Dyes4.3.5.1 Market size and forecast4.3.6 Beads4.3.6.1 Market size and forecast4.3.7 Others4.3.7.1 MArket size and forecast4.4 Software4.4.1 Key market trends4.4.2 Competitive landscape4.4.3 Key growth factors and opportunities4.4.4 Market size and forecast4.5 Services4.5.1 Key market trends4.5.2 Competitive landscape4.5.3 Key growth factors and opportunities4.5.4 Market size and forecastCHAPTER 5 WORLD FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2014-20225.1 Overview5.1.1 Market size and forecast5.2 Bead-based flow cytometry5.2.1 Key market trends5.2.2 Competitive landscape5.2.3 Key growth factors and opportunities5.2.4 Market size and forecast5.3 Cell based flow cytometers5.3.1 Key market trends5.3.2 Competitive landscape5.3.3 Key growth factors and opportunities5.3.4 Market size and forecastCHAPTER 6 WORLD FLOW CYTOMETRY MARKET, BY APPLICATION, 2014-20226.1 Overview6.1.1 Market size and forecast6.2 Academic and clinical applications6.2.1 Key market trends6.2.2 Competitive landscape6.2.3 Key growth factors and opportunities6.2.4 Market size and forecast6.2.5 Cell cycle analysis and cell proliferation6.2.5.1 Market size and forecast6.2.6 Apoptosis6.2.6.1 Market size and forecast6.2.7 Sorting/Screening6.2.7.1 Market size and forecast6.2.8 Transfection and cell viability6.2.8.1 Market size and forecast6.2.9 Others6.2.9.1 Market size and forecast6.3 Diagnostic applications6.3.1 Key market trends6.3.2 Competitive landscape6.3.3 Key growth factors and opportunities6.3.4 Market size and forecast6.3.5 Organ transplantation6.3.5.1 Market size and forecast6.3.6 Hematological malignancies6.3.6.1 Market size and forecast6.3.7 Cancer and solid tumor6.3.7.1 Market size and forecast6.3.8 HIV6.3.8.1 Market size and forecast6.3.9 Others6.3.9.1 Market size and forecastCHAPTER 7 WORLD FLOW CYTOMETRY MARKET, BY END USER, 2014-20227.1 Overview7.1.1 Market size and forecast7.2 Commercial organizations7.2.1 Key market trends7.2.2 Key growth factors and opportunities7.2.3 Market size and forecast7.3 Medical schools and clinical testing labs7.3.1 Key market trends7.3.2 Key growth factors and opportunities7.3.3 Market size and forecast7.4 Hospitals7.4.1 Key market trends7.4.2 Key growth factors and opportunities7.4.3 Market size and forecast7.5 Academic institutions7.5.1 Key market trends7.5.2 Key growth factors and opportunities7.5.3 Market size and forecast7.6 Others7.6.1 Market size and forecastCHAPTER 8 WORLD FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 2014-20228.1 Overview8.1.1 Market size and forecast8.2 North America8.2.1 Key market trends8.2.2 Competitive landscape8.2.3 Key growth factors and opportunities8.2.4 Market size and forecast8.3 Europe8.3.1 Key market trends8.3.2 Competitive landscape8.3.3 Key growth factors and opportunities8.3.4 Market size and forecast8.4 Asia Pacific8.4.1 Key market trends8.4.2 Competitive landscape8.4.3 Key growth factors and opportunities8.4.4 Market size and forecast8.5 LAMEA8.5.1 Key market trends8.5.2 Competitive landscape8.5.3 Key growth factors and opportunities8.5.4 Market size and forecastCHAPTER 9 COMPANY PROFILES9.1 Danaher Corporation (Beckman Coulter)9.1.1 Company overview9.1.2 Company snapshot9.1.3 Operating business segments9.1.4 Business performance9.1.5 Key strategic moves and developments9.1.6 SWOT analysis9.2 Affymetrix, Inc.9.2.1 Company overview9.2.2 Company snapshot9.2.3 Operating business segments9.2.4 Business performance9.2.5 Key strategic moves and developments9.2.6 SWOT analysis9.3 Sysmex Corporation9.3.1 Company overview9.3.2 Company snapshot9.3.3 Operating business segments9.3.4 Business performance9.3.5 Key strategic moves and developments9.3.6 SWOT Analysis9.4 Becton, Dickinson and Co.9.4.1 Company overview9.4.2 Company snapshot9.4.3 Operating business segments9.4.4 Business performance9.4.5 Key strategic moves and developments9.4.6 SWOT analysis9.5 Merck Millipore9.5.1 Company overview9.5.2 Company snapshot9.5.3 Business performance9.5.4 Key strategic moves and developments9.5.5 SWOT analysis9.6 Luminex Corporation9.6.1 Company overview9.6.2 Company snapshot9.6.3 Operating business segments9.6.4 Business performance9.6.5 Key strategic moves and developments9.6.6 SWOT Analysis9.7 Thermo Fisher Scientific9.7.1 Company overview9.7.2 Company snapshot9.7.3 Operating business segment9.7.4 Business performance9.7.5 Key strategic moves and developments9.7.6 SWOT analysis9.8 Bio-Rad Laboratories, Inc.9.8.1 Company overview9.8.2 Company snapshot9.8.3 Operating business segments9.8.4 Business performance9.8.5 Key strategic moves and developments9.8.6 SWOT analysis9.9 Miltenyi Biotec, GmbH.9.9.1 Company overview9.9.2 Company snapshot9.9.3 Operating business segments9.9.4 Business performance9.9.5 Key strategic moves and developments9.9.6 SWOT analysis.9.10 Dako (Agilent Technologies)9.10.1 Company overview9.10.2 Company snapshot9.10.3 Operating business segments9.10.4 Business performance9.10.5 Key strategic moves and developments9.10.6 SWOT analysisList of FiguresFIG. 1 FLOW CYTOMETRY MARKET DEFINITIONFIG. 2 TOP FACTORS IMPACTING WORLD FLOW CYTOMETRY MARKET (2014-2022)FIG. 3 TOP INVESTMENT POCKETS IN WORLD FLOW CYTOMETRY MARKETFIG. 4 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTIONFIG. 5 TOP WINNING STRATEGIES: NATURE AND TYPEFIG. 6 PORTERS FIVE FORCE ANALYSISFIG. 7 MARKET SHARE ANALYSIS, 2014FIG. 8 TYPES OF PLATFORMFIG. 9 NUMBER OF TRANSPLANTS PERFORMED IN THE UNITED STATES (2013)FIG. 10 ESTIMATED NEW CASES OF LEUKEMIA, LYMPHOMA AND MYELOMA (2014)FIG. 11 ESTIMATED NEW CASES OF LEUKEMIA, BY TYPE, (2013)FIG. 12 ESTIMATED NEW CASES AND DEATHS IN USA (2014)FIG. 13 TOP TEN COUNTRIES WITH CANCER POPULATION (PER 100,000 PEOPLE) 2013FIG. 14 PREVALENCE OF HIV/AIDS (TOP TEN COUNTRIES), 2013FIG. 15 ESTIMATED NUMBER OF NEW CANCER CASES AND DEATHS, BY SITES USA (2014)FIG. 16 DANAHER CORPORTAION, % REVENUE, BY BUSINESS SEGMENTS, (2014)FIG. 17 DANAHER CORPORATION, % REVENUE, BY GEOGRAPHY (2014)FIG. 18 SWOT ANALYSIS OF DANAHER CORPORATIONFIG. 19 EBIOSCIENCE SEGMENTS, REVENUE 2012-2014 ($MILLION)FIG. 20 AFFYMETRIX INC.%REVENUE, BY GEOGRAPHY (2014)FIG. 21 SWOT ANALYSIS OF AFFYMETRIX, INC.FIG. 22 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014FIG. 23 SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014FIG. 24 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)FIG. 25 SWOT ANALYSIS OF SYSMEX CORPORATIONFIG. 26 BECTON, DICKINSON AND COMPANY, % REVENUE BY BUSINESS SEGMENT (2014)FIG. 27 BECTON, DICKINSON AND COMPANY, % REVENUE, BY GEOGRAPHY (2014)FIG. 28 SWOT ANALYSIS OF BECTON, DICKINSON AND COMPANYFIG. 29 MERCK MILLIPORE, % REVENUE, BY BUSINESS SEGMENT (2014)FIG. 30 SWOT ANALYSIS OF MERCK MILLIPOREFIG. 31 LUMINEX CORPORATION,% REVENUE, BY GEOGRAPHY (2014)FIG. 32 SWOT ANALYSIS OF LUMINEX CORPORATIONFIG. 33 THERMO FISHER SCIENTIFIC, INC.%REVENUE, BY BUSINESS UNITS, 2014 ($MILLION)FIG. 34 THERMO FISHER SCIENTIFIC INC. REVENUE, 2012- 2014, ($MILLION)FIG. 35 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.FIG. 36 BIO-RAD LABORATORIES INC. REVENUE, 20122014, $MILLIONFIG. 37 BIO-RAD LABORATORIES% REVENUE, BY BUSINESS UNITS (2014)FIG. 38 BIO-RAD LABORATORIES% REVENUE, BY GEOGRAPHY (2014)FIG. 39 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.FIG. 40 SWOT ANALYSIS OF MILTENYI BIOTEC GMBHFIG. 41 AGILENT TECHNOLOGIES INC., %REVENUE BY BUSINESS UNITS, 2014 ($MILLION)FIG. 42 AGILENT TECHNOLOGIES, INC.% REVENUE BY GEOGRAPHY (2014)FIG. 43 SWOT ANALYSIS OF AGILENT TECHNOLOGIES, INC.List of TablesTABLE 1 WORLD FLOW CYTOMETRY MARKET, BY COMPONENT, 2014-2022 ($MILLION)TABLE 2 WORLD FLOW CYTOMETRY MARKET, BY INSTRUMENTS, 2014-2022 ($MILLION)TABLE 3 WORLD FLOW CYTOMETRY INSTRUMENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 4 WORLD FLOW CYTOMETRY INSTRUMENT MARKET, BY PLATFORMS, 2014-2022 ($MILLIONS)TABLE 5 WORLD FLOW CYTOMETRY PLATFORM MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 6 TYPES OF PLATFORMTABLE 7 TYPES OF SORTERSTABLE 8 WORLD FLOW CYTOMETRY SORTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 9 WORLD FLOW CYTOMETRY ANALYZERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 10 ANALYZERS BY KEY PLAYERSTABLE 11 WORLD FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY TYPES, 2014-2022 ($MILLION)TABLE 12 WORLD FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 13 TYPES OF FILTERSTABLE 14 WORLD FLOW CYTOMETRY FILTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 15 WORLD FLOW CYTOMETRY LASERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 16 TYPES OF DETECTORSTABLE 17 WORLD FLOW CYTOMETRY DETECTORS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 18 WORLD FLOW CYTOMETRY OTHER COMPONENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 19 WORLD FLOW CYTOMETRY ACCESSORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 20 WORLD FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY TYPE, 2014-2022 ($MILLION)TABLE 21 WORLD FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 22 WORLD FLOW CYTOMETRY ANTIBODIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 23 WORLD FLOW CYTOMETRY DYES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 24 WORLD FLOW CYTOMETRY BEADS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 25 WORLD FLOW CYTOMETRY OTHER REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 26 WORLD FLOW CYTOMETRY SOFTWARE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 27 WORLD FLOW CYTOMETRY SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 28 WORLD FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)TABLE 29 WORLD BEAD BASED FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 30 WORLD CELL BASED FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 31 WORLD FLOW CYTOMETRY MARKET, BY APPLICATION, 2014-2022 ($MILLION)TABLE 32 WORLD FLOW CYTOMETRY APPLICATION MARKET, BY ACADEMIC AND CLINICAL RESEARCH APPLICATION, 2014-2022 ($MILLION)TABLE 33 WORLD FLOW CYTOMETRY ACADEMIC AND CLINICAL RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 34 WORLD FLOW CYTOMETRY CELL CYCLE ANALYSIS AND CELL PROLIFERATION APPLICATIONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 35 WORLD FLOW CYTOMETRY APOPTOSIS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 36 WORLD FLOW CYTOMETRY SORTING/SCREENING, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 37 WORLD FLOW CYTOMETRY TRANSFECTION AND CELL VIABILITY, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 38 WORLD FLOW CYTOMETRY OTHER RESEARCH APPLICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 39 WORLD FLOW CYTOMETRY MARKET, BY DIAGNOSTIC APPLICATION, 2014-2022 ($MILLION)TABLE 40 WORLD FLOW CYTOMETRY DIAGNOSTIC APPLICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 41 WORLD FLOW CYTOMETRY ORGAN TRANSPLANT MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 42 WORLD FLOW CYTOMETRY HEMATOLOGICAL MALIGNANCIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 43 WORLD FLOW CYTOMETRY CANCER AND SOLID TUMOR MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 44 WORLD FLOW CYTOMETRY HIV INFECTION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 45 WORLD FLOW CYTOMETRY OTHER DIAGNOSTIC APPLICATION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)TABLE 46 WORLD FLOW CYTOMETRY MARKET, BY END USER, 2014-2022 ($MILLION)TABLE 47 WORLD FLOW CYTOMETRY COMMERCIAL ORGANIZATIONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 48 WORLD FLOW CYTOMETRY MEDICAL SCHOOLS AND CLINICAL TESTING LABS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)TABLE 49 WORLD FLOW CYTOMETRY HOSPITALS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 50 WORLD FLOW CYTOMETRY ACADEMIC INSTITUTION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)TABLE 51 WORLD FLOW CYTOMETRY OTHER END USER MARKET, BY GEOGRAPHY, 20142022 ($MILLION)TABLE 52 WORLD FLOW CYTOMETRY MARKET, BY GEOGRAPHY, 20142022 ($MILLION)TABLE 53 NORTH AMERICA FLOW CYTOMETRY MARKET, BY COMPONENT, 2014-2022 ($MILLION)TABLE 54 EUROPE FLOW CYTOMETRY MARKET, BY COMPONENT, 20142022 ($MILLION)TABLE 55 ASIA PACIFIC FLOW CYTOMETRY MARKET, BY COMPONENT, 20142022 ($MILLION)TABLE 56 LAMEA FLOW CYTOMETRY MARKET, BY COMPONENT, 20142022 ($MILLION)TABLE 57 COMPANY SNAPSHOT OF DANAHER CORPORATIONTABLE 58 DANAHER CORPORATION OPERATING SEGMENTSTABLE 59 COMPANY SPANSHOT OF AFFYMETRIX, INC.TABLE 60 AFFYMETIX INC., OPERATING SEGMENTSTABLE 61 SNAPSHOT OF SYSMEX CORPORATIONTABLE 62 SYSMEX CORPORATION, OPERATING SEGMENTSTABLE 63 COMPANY SNAPSHOT OF BECTON, DICKINSON AND COMPANYTABLE 64 BECTON , DICKINSON AND COMPANY OPERATING SEGMENTSTABLE 65 SNAPSHOT OF MERCK MILLIPORETABLE 66 COMPANY SNAPSHOT OF LUMINEX CORPORATIONTABLE 67 LUMINEX CORPORATION OPERATING SEGMENTSTABLE 68 COMPANY SNAPSHOT THERMO FISHER SCIENTIFIC INCTABLE 69 THERMO FISHER SCIENTIFIC INC. OPERATING SEGMENTSTABLE 70 COMPANY SNAPSHOT OF BIO-RAD LABORATORIES, INC.TABLE 71 BIO-RAD LABORATORIES, INC. OPERATING SEGMENTSTABLE 72 COMPANY SNAPSHOT OF MILTENYI BIOTEC GMBH.TABLE 73 MILTENYI BIOTEC, GMBH. OPERATING SEGMENTSTABLE 74 COMPANY SNAPSHOT OF AGILENT TECHNOLOGIES, INC.TABLE 75 AGILENT TECHNOLOGIES, INC., OPERATING SEGMENTS

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.